General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-21 | 2024-03 | 0 | N/A | N/A | N/A |
2024-05-07 | 2023-12 | -0.52 | N/A | N/A | N/A |
2023-11-14 | 2023-09 | -0.92 | -0.64 | 0.28 | 30.43% |
2023-08-15 | 2023-06 | -0.52 | -0.69 | -0.17 | -32.69% |
2023-05-16 | 2023-03 | -0.85 | -0.78 | 0.07 | 8.24% |
2023-03-30 | 2022-12 | -1.4 | N/A | N/A | N/A |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-06-13 | BROIDRICK AMY S | President | 34.50K | Purchase |
2020-03-11 | DOYLE NOAH J | Director | 0.00 | Sale |
2020-04-09 | FOEHR MATTHEW W | Director | 138.64K | Stock Award(Grant) |
2017-10-02 | JAVELIN VENTURE PARTNERS, L.P. | Beneficial Owner of more than 10% of a Class of Security | 7.05M | Purchase |
2021-08-18 | KRUGER KURT H | Director | 18.00K | Purchase |
2021-04-15 | LOTZ CHRISTOPHER L | Chief Financial Officer | 12.54K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 25.84K | 23.54K | 0.51% |
2023-06-29 | Geode Capital Management, LLC | 22.15K | 20.18K | 0.44% |
2023-06-29 | State Street Corporation | 10.93K | 9.96K | 0.22% |
2023-09-29 | Highmark Wealth Management LLC | 8.01K | 8.09K | 0.16% |
2023-06-29 | Tower Research Capital LLC (TRC) | 4.61K | 4.20K | 0.09% |
2023-06-29 | UBS Group AG | 1.37K | 1.25K | 0.03% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-05-30 | Fidelity Extended Market Index Fund | 11.85K | 10.93K | 0.23% |
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 4.89K | 4.51K | 0.10% |
2023-05-30 | Fidelity Series Total Market Index Fund | 2.93K | 2.70K | 0.06% |
2023-05-30 | Fidelity Total Market Index Fund | 1.51K | 1.40K | 0.03% |
Split | Date |
---|---|
1 : 10 | 2022-11-23 |
1 : 25 | 2020-05-26 |
1 : 10 | 2018-03-23 |
Based on analysis for future income revenues from products, they put a 9 dollar price point on this stock. Cash on hand to fund operations all thru next year. Solid
For the new buyers https://www.benzinga.com/amp/content/24244115
Going higher higher
https://news.futunn.com/en/post/11312383?src=2&futusource=news_stock_stockpagenews&report_type=stock&report_id=19984820&skintype=3&main_broker=WwogIDEwMDEKXQ==&level=1&data_ticket=47ab8e3f51ca50b79824fd0525372866&utm_medium=futu_niuniu_share&utm_content=web_share&utm_campaign=news&utm_term=19984820 Why Are Qualigen Therapeutics Shares Surging During Premarket Tuesday?
Breaking $3 now .. no more share available for borrowing
It’s zooming higher $$
https://s27.q4cdn.com/906368049/files/News/2021/Zacks_SCR_Research_11222021_QLGN_Bautz.pdf
$QLGN this will be massive tomorrow.
$QLGN there was 10M Volume today on this stock so you cannot say it was largely ignored
$QLGN Pump after hours and sell during the day - nice gig for some BS for most
We need to come to the conclusion that this could drop much lower as the market participants are moving more money from equity to crypto. Particularly when it comes to small biotechs, same risk as crypto but cryptos offer a better return so far on 1 year basis.
Our hope: very strong PR or crypto crashes